Management of Coronary Artery Fistula to Pulmonary Artery
Transcatheter occlusion is the recommended first-line treatment for coronary artery fistulas to the pulmonary artery, particularly for symptomatic patients and moderate to large asymptomatic fistulas. 1, 2
Clinical Significance and Presentation
- Coronary artery fistulas (CAFs) represent the second most common coronary artery anomaly with an incidence of 0.1% to 0.2% of catheterized patients 2
- Most commonly arise from either the right coronary artery or left anterior descending artery 2
- Patients may present with:
Diagnostic Evaluation
- Echocardiography is the initial imaging modality but may have limitations 2
- CT angiography or MRI is recommended for detailed anatomical evaluation 2
- Cardiac catheterization with coronary angiography is necessary for precise delineation of coronary anatomy and assessment of hemodynamics 2, 3
Treatment Indications
Class I indications (strongly recommended):
Class IIa indications (reasonable to perform):
Class III indications (not recommended):
- Transcatheter device occlusion is not indicated for clinically insignificant coronary arteriovenous fistulae (e.g., normal-sized cardiac chambers) 1
Treatment Options
1. Transcatheter Closure (Preferred First-Line Approach)
- Preferred for suitable anatomy due to less invasiveness 2
- Can be performed with coils or other occluding devices 2, 5
- Advantages include shorter hospital stay and avoidance of thoracotomy and cardiopulmonary bypass 4
- Potential complications include:
2. Surgical Closure
- Indicated when:
- Should be performed by surgeons with training and expertise in congenital heart disease 2
Follow-up Recommendations
- Patients with small, asymptomatic CAFs should have clinical follow-up with echocardiography every 3 to 5 years 2
- Patients with treated CAFs require intermediate and long-term follow-up due to potential residual abnormalities 2
- Monitoring for recurrence, residual shunts, or development of coronary artery stenosis is essential 4